Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-03-14 to 2024-03-15
Current total value of award: $1067
Description: 4563963849!CLONAZEPAM 0.5 MG TABLET UD 100S